Gene · 51115
Papers3,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease. | Protein Sci | 2026 | 42192571 | PubTator, text mining | PubMed |
| Tracheal aspirates of mechanically ventilated preterm infants possess cytopathic tau variants: a prospective exploratory study. | Am J Physiol Lung Cell Mol Physiol | 2026 | 42161310 | PubTator, text mining | PubMed |
| SAPCD2 phosphorylation modulates astral microtubule stability to control spindle orientation. | Commun Biol | 2026 | 42151476 | PubTator, text mining | PubMed |
| A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors. | J Med Chem | 2026 | 42054438 | PubTator, text mining | PubMed |
| Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease. | Acta Neuropathol | 2026 | 42017968 | PubTator, text mining | PubMed |
| Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy. | Alzheimers Dement | 2026 | 41923154 | PubTator, text mining | PubMed |
| Tau Pathology in Chronic Traumatic Encephalopathy: Mechanisms and Diagnostic Advances. | Yale J Biol Med | 2026 | 41918502 | PubTator, text mining | PubMed |
| A pathogenic Tau mutation drives autophagy-lysosome dysfunction that limits Tau degradation in a model of frontotemporal dementia. | Nat Commun | 2026 | 41916975 | PubTator, text mining | PubMed |
| Synapse-associated neuropathological markers in Alzheimer's disease. | Brain | 2026 | 41906816 | PubTator, text mining | PubMed |
| G-protein coupled receptor chemokine CX3CR1 influences extracellular Tau internalization in Alzheimer's disease. | Adv Protein Chem Struct Biol | 2026 | 41904008 | PubTator, text mining | PubMed |
| Actin-associated growth cone of Tau and its intracellular localization. | Adv Protein Chem Struct Biol | 2026 | 41904001 | PubTator, text mining | PubMed |
| Tau Protein Aggregation Inhibitors-Therapeutic Strategy for Concurrent Tau and Amyloid Aggregation Inhibition. | Biomedicines | 2026 | 41898169 | PubTator, text mining | PubMed |
| Genetic associations of variants in 10 glaucoma-related genes with POAG risk and structural phenotypes in Korean subjects. | Medicine (Baltimore) | 2026 | 41894275 | PubTator, text mining | PubMed |
| Misfolded Proteins and Cognitive Decline: Mechanistic Insights into Neurodegenerative Disorders. | Neurol Int | 2026 | 41893050 | PubTator, text mining | PubMed |
| Architects of the Developing Brain: Cytoskeleton-Organizing Molecules in Neurodevelopmental Disorders. | Cells | 2026 | 41892327 | PubTator, text mining | PubMed |
| A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease. | Acta Neuropathol | 2026 | 41851356 | PubTator, text mining | PubMed |
| Measurement of Tau Protein and Aβ Amyloid Plaques in Postmortem Human Brains of Down Syndrome and Alzheimer's Disease by Using [125I]IPPI and [125I]IBETA Autoradiography. | Synapse | 2026 | 41840857 | PubTator, text mining | PubMed |
| Serum biomarker trajectory clusters predict functional outcome and quality of life for traumatic brain injury. | Brain Commun | 2026 | 41809435 | PubTator, text mining | PubMed |
| Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial. | BMJ Neurol Open | 2026 | 41789119 | PubTator, text mining | PubMed |
| Closed, pumpless microphysiological system with unidirectional flow for co-culture and focal irradiation. | RSC Adv | 2026 | 41757311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51115/papers?page=2